{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:17:03Z","timestamp":1794003423984,"version":"4.8.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Research Foundation (NRF) Thuthuka programme","award":["TTK23030380657"],"award-info":[{"award-number":["TTK23030380657"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-39483-7","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T12:03:32Z","timestamp":1771070612000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain"],"prefix":"10.1038","volume":"16","author":[{"given":"Zurika","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lique","family":"Lewies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes Frederik","family":"Wentzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marietjie","family":"Schutte-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Erasmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwar","family":"Noreljaleel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9012-436X","authenticated-orcid":false,"given":"Abdul Rashid","family":"Issahaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"39483_CR1","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s12231-008-9033-8","volume":"62","author":"G Guzm\u00e1n","year":"2008","unstructured":"Guzm\u00e1n, G. Hallucinogenic mushrooms in mexico: an overview. Econ. Bot. 62, 404\u2013412 (2008).","journal-title":"Econ. Bot."},{"key":"39483_CR2","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","volume":"187","author":"RR Griffiths","year":"2006","unstructured":"Griffiths, R. R., Richards, W. A., McCann, U. & Jesse, R. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacol. (Berl). 187, 268\u2013283 (2006).","journal-title":"Psychopharmacol. (Berl)"},{"key":"39483_CR3","doi-asserted-by":"crossref","unstructured":"Plazas, E. & Faraone, N. Indole Alkaloids from Psychoactive Mushrooms: Chemical and Pharmacological Potential as Psychotherapeutic Agents. Biomedicines 11, (2023).","DOI":"10.3390\/biomedicines11020461"},{"key":"39483_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41429-020-0311-8","volume":"73","author":"DE Nichols","year":"2020","unstructured":"Nichols, D. E. Psilocybin: from ancient magic to modern medicine. J. Antibiot. (Tokyo). 73, 679\u2013686 (2020).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"39483_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","volume":"68","author":"CS Grob","year":"2011","unstructured":"Grob, C. S. et al. Pilot study of psilocybin treatment for anxiety in patients with Advanced-Stage cancer. Arch. Gen. Psychiatry. 68, 71\u201378 (2011).","journal-title":"Arch. Gen. Psychiatry"},{"key":"39483_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","volume":"172","author":"F Hasler","year":"2004","unstructured":"Hasler, F., Grimberg, U., Benz, M. A., Huber, T. & Vollenweider, F. X. Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study. Psychopharmacol. (Berl). 172, 145\u2013156 (2004).","journal-title":"Psychopharmacol. (Berl)"},{"key":"39483_CR7","unstructured":"Psychedelic therapy -. Statistics & Facts | Statista. https:\/\/www.statista.com\/topics\/4277\/psychedelic-therapy\/"},{"key":"39483_CR8","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/dta.2950","volume":"13","author":"K Gotvaldov\u00e1","year":"2021","unstructured":"Gotvaldov\u00e1, K. et al. Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom psilocybe Cubensis. Drug Test. Anal. 13, 439\u2013446 (2021).","journal-title":"Drug Test. Anal."},{"key":"39483_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/dta.1400","volume":"5","author":"M Pellegrini","year":"2013","unstructured":"Pellegrini, M. et al. Magic truffles or philosopher\u2019s stones: a legal way to sell psilocybin? Drug Test. Anal. 5, 182\u2013185 (2013).","journal-title":"Drug Test. Anal."},{"key":"39483_CR10","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1007\/s00213-018-5049-7","volume":"235","author":"L Prochazkova","year":"2018","unstructured":"Prochazkova, L. et al. Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting. Psychopharmacol. (Berl). 235, 3401\u20133413 (2018).","journal-title":"Psychopharmacol. (Berl)"},{"key":"39483_CR11","doi-asserted-by":"publisher","DOI":"10.1556\/2054.2024.00379","author":"P Kryskow","year":"2024","unstructured":"Kryskow, P. et al. The mushroom was more alive and vibrant: patient reports of synthetic versus organic forms of psilocybin. J. Psychedelic Stud. https:\/\/doi.org\/10.1556\/2054.2024.00379 (2024).","journal-title":"J. Psychedelic Stud."},{"key":"39483_CR12","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1271\/bbb.90095","volume":"73","author":"Y MATSUSHIMA","year":"2009","unstructured":"MATSUSHIMA, Y., KIKURA-HANAJIRI, S. H. I. R. O. T. A. O., GODA, R., EGUCHI, F. & Y. & Effects of psilocybe argentipes on Marble-Burying behavior in mice. Biosci. Biotechnol. Biochem. 73, 1866\u20131868 (2009).","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"39483_CR13","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1038\/s41380-024-02477-w","volume":"29","author":"O. Shahar","year":"2024","unstructured":"Shahar, O. et al. Effect of chemically synthesized psilocybin and psychedelic mushroom extract on molecular and metabolic profiles in mouse brain. Mol. Psychiatry. 29, 2059\u20132073. (2024). https:\/\/doi.org\/10.1038\/s41380-024-02477-w","journal-title":"Mol. Psychiatry"},{"key":"39483_CR14","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim, S. et al. PubChem substance and compound databases. Nucleic Acids Res. 44, D1202\u2013D1213 (2016).","journal-title":"Nucleic Acids Res."},{"key":"39483_CR15","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A. Daina","year":"2017","unstructured":"Daina, A., Michielin, O., Zoete, V. & SwissADME A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717. (2017). https:\/\/doi.org\/10.1038\/srep42717","journal-title":"Sci. Rep."},{"key":"39483_CR16","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu, D. et al. The blood\u2013brain barrier: structure, regulation, and drug delivery. Signal. Transduct. Target. Ther. 8, 217 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"39483_CR17","doi-asserted-by":"publisher","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","volume":"44","author":"MK Gilson","year":"2016","unstructured":"Gilson, M. K. et al. BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems Pharmacology. Nucleic Acids Res. 44, D1045\u2013D1053 (2016).","journal-title":"Nucleic Acids Res."},{"key":"39483_CR18","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013W364 (2019).","journal-title":"Nucleic Acids Res."},{"key":"39483_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.tibs.2023.03.003","volume":"48","author":"J Durham","year":"2023","unstructured":"Durham, J., Zhang, J., Humphreys, I. R., Pei, J. & Cong, Q. Recent advances in predicting and modeling protein\u2013protein interactions. Trends Biochem. Sci. 48, 527\u2013538 (2023).","journal-title":"Trends Biochem. Sci."},{"key":"39483_CR20","doi-asserted-by":"crossref","unstructured":"Shannon, P. et al. Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. Genome Res. 13, 2498\u20132504 (2003).","DOI":"10.1101\/gr.1239303"},{"key":"39483_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12859-023-05425-7","volume":"24","author":"MV Palukuri","year":"2023","unstructured":"Palukuri, M. V., Patil, R. S. & Marcotte, E. M. Molecular complex detection in protein interaction networks through reinforcement learning. BMC Bioinform. 24, 306 (2023).","journal-title":"BMC Bioinform."},{"key":"39483_CR22","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"key":"39483_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0294236","volume":"18","author":"D Tang","year":"2023","unstructured":"Tang, D. et al. SRplot: A free online platform for data visualization and graphing. PLoS One. 18, 1\u20138 (2023).","journal-title":"PLoS One"},{"key":"39483_CR24","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: a new approach for Rapid, accurate Docking and Scoring. 1. Method and assessment of Docking accuracy. J. Med. Chem. 47, 1739 (2004).","journal-title":"J. Med. Chem."},{"key":"39483_CR25","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu, C. et al. OPLS4: improving force field accuracy on challenging regimes of chemical space. J. Chem. Theory Comput. 17, 4291\u20134300 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"39483_CR26","unstructured":"Schr\u00f6dinger Release 2024-2: LigPrep, Schr\u00f6dinger, LLC, New York, NY, 2024."},{"key":"39483_CR27","unstructured":"Shaw, D. E. Desmond Molecular Dynamics System. (2021)."},{"key":"39483_CR28","doi-asserted-by":"publisher","unstructured":"Issahaku, A. R., Wilhelm, A., Schutte-Smith, M., Erasmus, E. & Visser, H. Elucidating the binding mechanisms of GABA and muscimol as an avenue to discover novel GABA-mimetic small molecules. J. Biomol. Struct. Dyn. 1\u201316. https:\/\/doi.org\/10.1080\/07391102.2024.2331088 (2024).","DOI":"10.1080\/07391102.2024.2331088"},{"key":"39483_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","volume":"138","author":"UM Zanger","year":"2013","unstructured":"Zanger, U. M. & Schwab, M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol. Ther. 138, 103\u2013141 (2013).","journal-title":"Pharmacol. Ther."},{"key":"39483_CR30","doi-asserted-by":"publisher","first-page":"e18636","DOI":"10.7717\/peerj.18636","volume":"12","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. CYP3A4 and CYP3A5: the crucial roles in clinical drug metabolism and the significant implications of genetic polymorphisms. PeerJ 12, e18636 (2024).","journal-title":"PeerJ"},{"key":"39483_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/1355621021000005937","volume":"7","author":"T Passie","year":"2002","unstructured":"Passie, T., Seifert, J., Schneider, U. & Emrich, H. M. The Pharmacology of psilocybin. Addict. Biol. 7, 357\u2013364 (2002).","journal-title":"Addict. Biol."},{"key":"39483_CR32","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuropharm.2011.01.017","volume":"61","author":"AL Halberstadt","year":"2011","unstructured":"Halberstadt, A. L. & Geyer, M. A. Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology 61, 364\u2013381 (2011).","journal-title":"Neuropharmacology"},{"key":"39483_CR33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.euroneuro.2013.12.006","volume":"24","author":"F Tyl\u0161","year":"2014","unstructured":"Tyl\u0161, F., P\u00e1len\u00ed\u010dek, T. & Hor\u00e1\u010dek, J. Psilocybin\u2013summary of knowledge and new perspectives. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 24, 342\u2013356 (2014).","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"39483_CR34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/2045125316676092","volume":"7","author":"A Mahapatra","year":"2017","unstructured":"Mahapatra, A. & Gupta, R. Role of psilocybin in the treatment of depression. Ther. Adv. Psychopharmacol. 7, 54\u201356 (2017).","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"39483_CR35","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/14737175.2016.1220834","volume":"17","author":"BTH de Veen","year":"2017","unstructured":"de Veen, B. T. H., Schellekens, A. F. A., Verheij, M. M. M. & Homberg, J. R. Psilocybin for treating substance use disorders? Expert Rev. Neurother. 17, 203\u2013212 (2017).","journal-title":"Expert Rev. Neurother."},{"key":"39483_CR36","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3389\/fnhum.2017.00484","volume":"11","author":"AG Fischer","year":"2017","unstructured":"Fischer, A. G. & Ullsperger, M. An update on the role of serotonin and its interplay with dopamine for reward. Front. Hum. Neurosci. 11, 484 (2017).","journal-title":"Front. Hum. Neurosci."},{"key":"39483_CR37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.pharmthera.2006.08.004","volume":"113","author":"KD Alex","year":"2007","unstructured":"Alex, K. D. & Pehek, E. A. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 113, 296\u2013320 (2007).","journal-title":"Pharmacol. Ther."},{"key":"39483_CR38","doi-asserted-by":"crossref","unstructured":"Di Giovanni, G., Di Matteo, V. & Esposito, E. Serotonin-dopamine interaction: experimental evidence and therapeutic relevance. Preface. Progress in brain research. 172 ix (2008).","DOI":"10.1016\/S0079-6123(08)00931-X"},{"key":"39483_CR39","doi-asserted-by":"crossref","unstructured":"Stahl\u2019s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications. in Stahl\u2019s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications (ed. Stahl, S. M.) i\u2013i. Cambridge University Press, (2021).","DOI":"10.1017\/9781108975292"},{"key":"39483_CR40","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","volume":"110","author":"MJ Millan","year":"2006","unstructured":"Millan, M. J. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol. Ther. 110, 135\u2013370 (2006).","journal-title":"Pharmacol. Ther."},{"key":"39483_CR41","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1042\/BJ20110293","volume":"438","author":"ER Werner","year":"2011","unstructured":"Werner, E. R., Blau, N. & Th\u00f6ny, B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem. J. 438, 397\u2013414 (2011).","journal-title":"Biochem. J."},{"key":"39483_CR42","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1006\/bbrc.2001.4887","volume":"283","author":"DP Singh","year":"2001","unstructured":"Singh, D. P., Fatma, N., Kimura, A., Chylack, L. T. & Shinohara, T. LEDGF binds to heat shock and Stress-Related element to activate the expression of Stress-Related genes. Biochem. Biophys. Res. Commun. 283, 943\u2013955 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"39483_CR43","first-page":"5074","volume":"60","author":"T Su","year":"2000","unstructured":"Su, T. et al. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a Tobacco-specific Carcinogen, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone1. Cancer Res. 60, 5074\u20135079 (2000).","journal-title":"Cancer Res."},{"key":"39483_CR44","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.euroneuro.2018.03.016","volume":"28","author":"O Grimm","year":"2018","unstructured":"Grimm, O., Kraehenmann, R., Preller, K. H., Seifritz, E. & Vollenweider, F. X. Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination. Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol. 28, 691\u2013700 (2018).","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"39483_CR45","doi-asserted-by":"publisher","first-page":"285","DOI":"10.14704\/nq.2016.14.2.943","volume":"14","author":"JA Zamaria","year":"2016","unstructured":"Zamaria, J. A. A phenomenological examination of psilocybin use and its positive and persisting aftereffects. Neuroquantology 14, 285\u2013296 (2016).","journal-title":"Neuroquantology"},{"key":"39483_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S2215-0366(15)00576-3","volume":"3","author":"MC Mithoefer","year":"2016","unstructured":"Mithoefer, M. C., Grob, C. S. & Brewerton, T. D. Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. Lancet Psychiatry. 3, 481\u2013488 (2016).","journal-title":"Lancet Psychiatry"},{"key":"39483_CR47","doi-asserted-by":"publisher","first-page":"10544","DOI":"10.1523\/JNEUROSCI.3007-12.2013","volume":"33","author":"M Kometer","year":"2013","unstructured":"Kometer, M., Schmidt, A., J\u00e4ncke, L. & Vollenweider, F. X. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on \u03b1 oscillations, N170 visual-evoked potentials, and visual hallucinations. J. Neurosci. Off J. Soc. Neurosci. 33, 10544\u201310551 (2013).","journal-title":"J. Neurosci. Off J. Soc. Neurosci."},{"key":"39483_CR48","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1002\/hbm.22562","volume":"35","author":"E Tagliazucchi","year":"2014","unstructured":"Tagliazucchi, E., Carhart-Harris, R., Leech, R., Nutt, D. & Chialvo, D. R. Enhanced repertoire of brain dynamical States during the psychedelic experience. Hum. Brain Mapp. 35, 5442\u20135456 (2014).","journal-title":"Hum. Brain Mapp."},{"key":"39483_CR49","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neuroimage.2019.05.060","volume":"199","author":"LD Lord","year":"2019","unstructured":"Lord, L. D. et al. Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin. Neuroimage 199, 127\u2013142 (2019).","journal-title":"Neuroimage"},{"key":"39483_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1161\/01.RES.0000082524.34487.31","volume":"93","author":"A Friebe","year":"2003","unstructured":"Friebe, A. & Koesling, D. Regulation of nitric oxide-sensitive Guanylyl cyclase. Circ. Res. 93, 96\u2013105 (2003).","journal-title":"Circ. Res."},{"key":"39483_CR51","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0031-6997(24)01457-1","volume":"52","author":"KA Lucas","year":"2000","unstructured":"Lucas, K. A. et al. Guanylyl cyclases and signaling by Cyclic GMP. Pharmacol. Rev. 52, 375\u2013414 (2000).","journal-title":"Pharmacol. Rev."},{"key":"39483_CR52","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","volume":"235","author":"RL Carhart-Harris","year":"2018","unstructured":"Carhart-Harris, R. L. et al. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacol. (Berl). 235, 399\u2013408 (2018).","journal-title":"Psychopharmacol. (Berl)"},{"key":"39483_CR53","doi-asserted-by":"publisher","first-page":"8439","DOI":"10.1523\/JNEUROSCI.1121-22.2022","volume":"42","author":"SF Grieco","year":"2022","unstructured":"Grieco, S. F. et al. Psychedelics and neural plasticity: therapeutic implications. J. Neurosci. Off J. Soc. Neurosci. 42, 8439\u20138449 (2022).","journal-title":"J. Neurosci. Off J. Soc. Neurosci."},{"key":"39483_CR54","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3109\/00207454.2013.785949","volume":"123","author":"Z Zheng","year":"2013","unstructured":"Zheng, Z., Yingtong, Z., Wu, J. & and Increased neuroplasticity May protect against cardiovascular disease. Int. J. Neurosci. 123, 599\u2013608 (2013).","journal-title":"Int. J. Neurosci."},{"key":"39483_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2022.792798","volume":"13","author":"G Numata","year":"2022","unstructured":"Numata, G., Takimoto, E. & Cyclic GMP and PKG signaling in heart failure. Front. Pharmacol. 13, 1\u201311 (2022).","journal-title":"Front. Pharmacol."},{"issue":"9","key":"39483_CR56","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.3390\/plants9091127","volume":"9","author":"S. M. Nkadimeng","year":"2020","unstructured":"Nkadimeng, S. M., Nabatanzi, A., Steinmann, C. M. L. & Eloff, J. N. Phytochemical, cytotoxicity, antioxidant and anti-inflammatory effects of Psilocybe natalensis magic mushroom. Plants 9 (9), 1127. (2020). https:\/\/doi.org\/10.3390\/plants9091127","journal-title":"Plants"},{"key":"39483_CR57","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2217\/pmt-2017-0068","volume":"8","author":"A Whelan","year":"2018","unstructured":"Whelan, A. & Johnson, M. I. Lysergic acid diethylamide and psilocybin for the management of patients with persistent pain: a potential role? Pain Manag. 8, 217\u2013229 (2018).","journal-title":"Pain Manag"},{"key":"39483_CR58","doi-asserted-by":"publisher","unstructured":"Repasky, M. P., Shelley, M. & Friesner, R. A. Flexible ligand docking with Glide. Current Protocols in Bioinformatics, Chapter 8, Unit 8.12 (2007). https:\/\/doi.org\/10.1002\/0471250953.bi0812s18","DOI":"10.1002\/0471250953.bi0812s18"},{"key":"39483_CR59","unstructured":"Schr\u00f6dinger, L. L. C. & Maestro Version 13.9.138; MMshare, Version 6.5.138, Release 2024-1. (2024)."},{"key":"39483_CR60","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0026-895X(25)13677-8","volume":"43","author":"CD Wang","year":"1993","unstructured":"Wang, C. D., Gallaher, T. K. & Shih, J. C. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation. Mol. Pharmacol. 43, 931\u2013940 (1993).","journal-title":"Mol. Pharmacol."},{"key":"39483_CR61","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0022-3565(24)39293-6","volume":"293","author":"K Kristiansen","year":"2000","unstructured":"Kristiansen, K. et al. A highly conserved aspartic acid (Asp-155) anchors the terminal amine moiety of tryptamines and is involved in membrane targeting of the 5-HT2A serotonin receptor but does not participate in activation via a Salt-Bridge disruption Mechanism11This study. J. Pharmacol. Exp. Ther. 293, 735\u2013746 (2000).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"39483_CR62","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","volume":"182","author":"K Kim","year":"2020","unstructured":"Kim, K. et al. Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A serotonin receptor. Cell 182, 1574\u20131588e19 (2020).","journal-title":"Cell"},{"key":"39483_CR63","unstructured":"Dassault Syst\u00e8mes, B. I. O. V. I. A. BIOVIA Discovery Studio Client, Version 19.1.0.18287. (2019)."},{"key":"39483_CR64","doi-asserted-by":"publisher","first-page":"100607","DOI":"10.1016\/j.rechem.2022.100607","volume":"4","author":"T Myburg","year":"2022","unstructured":"Myburg, T., Petzer, A. & Petzer, J. P. The Inhibition of monoamine oxidase by Harmine derivatives. Results Chem. 4, 100607 (2022).","journal-title":"Results Chem."},{"key":"39483_CR65","doi-asserted-by":"publisher","first-page":"342161","DOI":"10.1016\/j.aca.2023.342161","volume":"1288","author":"R Goff","year":"2024","unstructured":"Goff, R. et al. Determination of psilocybin and Psilocin content in multiple psilocybe Cubensis mushroom strains using liquid chromatography - tandem mass spectrometry. Anal. Chim. Acta. 1288, 342161 (2024).","journal-title":"Anal. Chim. Acta"},{"issue":"2","key":"39483_CR66","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/jof11020099","volume":"11","author":"E. Kurzbaum","year":"2025","unstructured":"Kurzbaum, E., P\u00e1len\u00ed\u010dek, T., Shrchaton, A., Azerrad, S. & Dekel, Y. Exploring Psilocybe cubensis strains: cultivation techniques, psychoactive compounds, genetics and research gaps. J. Fungi. 11 (2), 99. (2025). https:\/\/doi.org\/10.3390\/jof11020099","journal-title":"J. Fungi"},{"key":"39483_CR67","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1021\/acschemneuro.5b00033","volume":"6","author":"T Holloway","year":"2015","unstructured":"Holloway, T. & Gonz\u00e1lez-Maeso, J. Epigenetic mechanisms of serotonin signaling. ACS Chem. Neurosci. 6, 1099\u20131109 (2015).","journal-title":"ACS Chem. Neurosci."},{"key":"39483_CR68","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0893-133X(98)00108-0","volume":"20","author":"FX Vollenweider","year":"1999","unstructured":"Vollenweider, F. X., Vontobel, P., Hell, D. & Leenders, K. L. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man\u2013a PET study with [11\u00a0C]raclopride. Neuropsychopharmacol. Off Publ Am. Coll. Neuropsychopharmacol. 20, 424\u2013433 (1999).","journal-title":"Neuropsychopharmacol. Off Publ Am. Coll. Neuropsychopharmacol."},{"key":"39483_CR69","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.neuropharm.2011.01.015","volume":"61","author":"R Andrade","year":"2011","unstructured":"Andrade, R. Serotonergic regulation of neuronal excitability in the prefrontal cortex. Neuropharmacology 61, 382\u2013386 (2011).","journal-title":"Neuropharmacology"},{"key":"39483_CR70","doi-asserted-by":"crossref","unstructured":"Carhart-Harris, R. L. et al. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc. Natl. Acad. Sci. U. S. A. 109, 2138\u20132143 (2012).","DOI":"10.1073\/pnas.1119598109"},{"key":"39483_CR71","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1177\/02698811221092508","volume":"36","author":"R Smausz","year":"2022","unstructured":"Smausz, R., Neill, J. & Gigg, J. Neural mechanisms underlying psilocybin\u2019s therapeutic potential - the need for preclinical in vivo electrophysiology. J. Psychopharmacol. 36, 781\u2013793 (2022).","journal-title":"J. Psychopharmacol."},{"key":"39483_CR72","doi-asserted-by":"crossref","unstructured":"Nichols, C. D. Serotonin 5-HT(2A) Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases. Cardiovasc. Psychiatry Neurol. 475108 (2009). (2009).","DOI":"10.1155\/2009\/475108"},{"key":"39483_CR73","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1007\/s43440-023-00539-4","volume":"75","author":"A Ws\u00f3\u0142","year":"2023","unstructured":"Ws\u00f3\u0142, A. Cardiovascular safety of psychedelic medicine: current status and future directions. Pharmacol. Rep. 75, 1362\u20131380 (2023).","journal-title":"Pharmacol. Rep."},{"key":"39483_CR74","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/chem.201904363","volume":"26","author":"F Blei","year":"2020","unstructured":"Blei, F. et al. Simultaneous production of psilocybin and a cocktail of \u03b2-Carboline monoamine oxidase inhibitors in \u2018Magic\u2019 mushrooms. Chemistry 26, 729\u2013734 (2020).","journal-title":"Chemistry"},{"key":"39483_CR75","doi-asserted-by":"publisher","unstructured":"Ray, T. S. & Correction Psychedelics and the human receptorome. PLoS One. 5 https:\/\/doi.org\/10.1371\/annotation\/e580a864-cf13-40c2-9bd9-b9687a6 (2010).","DOI":"10.1371\/annotation\/e580a864-cf13-40c2-9bd9-b9687a6"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39483-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39483-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39483-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T14:02:50Z","timestamp":1773669770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-39483-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["39483"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-39483-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9016"}}